• Home
  • About the Grant
    • Background
    • Grant Application
    • FAQs
  • Grantees
    • Hong Kong
    • India
    • Indonesia
    • Japan
    • Laos
    • Malaysia
    • Pakistan
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Stories
    • Commentary
    • Videos
    • Blogs
    • Photo Series
  • Media
    • News
    • Press
  • Home
  • About the Grant
    • Background
    • Grant Application
    • FAQs
  • Grantees
    • Hong Kong
    • India
    • Indonesia
    • Japan
    • Laos
    • Malaysia
    • Pakistan
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Stories
    • Commentary
    • Videos
    • Blogs
    • Photo Series
  • Media
    • News
    • Press
  • ZH
EN
ZH

Commentary

  • Share

Q&A: Health workers as the key to stigma-free HIV care

By Devex Editor

The International AIDS Society's Lucy Stackpool-Moore explains the impact stigma in a health setting can have for those living with HIV, how to create an environment that is judgement-free, and the role of the Me & My Healthcare Provider campaign in achieving that.
Read More

Links redirecting out of this site are provided as a convenience but are not Gilead property nor are controlled by Gilead. Thus, Gilead is not responsible for their content or your use of them.

Close Leave site

Opinion: Youths have the power to address Asia’s blind spot

By Devex Editor

Youths have the opportunity to lead the charge and address the rise in sexually transmitted infections, such as HIV, in Asia. Pioneering open dialogues around sexual health will increase access and support for every person that needs it.
Read More

Links redirecting out of this site are provided as a convenience but are not Gilead property nor are controlled by Gilead. Thus, Gilead is not responsible for their content or your use of them.

Close Leave site

Q&A: COVID-19’s economic impact on women living with HIV

By Devex Editor

COVID-19 has impacted livelihoods the world over. Shreepal Saptasagar, director at Yerala Projects Society, shares how this affects women living with HIV in India and the efforts put towards supporting them.
Read More

Links redirecting out of this site are provided as a convenience but are not Gilead property nor are controlled by Gilead. Thus, Gilead is not responsible for their content or your use of them.

Close Leave site

Opinion: Lessons learnt from the evolutions of HIV treatment

By Devex Editor

Taiwan has already achieved 90-93-95 on the UNAIDS targets. However, to meet the Fourth-90 target, Prof Hung believes that lessons learned from the past will help understand how to streamline and integrate HIV care in the future to reach the next milestone.
Read More

Links redirecting out of this site are provided as a convenience but are not Gilead property nor are controlled by Gilead. Thus, Gilead is not responsible for their content or your use of them.

Close Leave site

Opinion: How to reduce HIV-related stigma and discrimination in health facilities

By Devex Editor

HIV-related stigma in health care settings poses a barrier to the continuity of care and life-prolonging treatment. Dr Bruce Agins and Daniel Ikeda explain how a new initiative can help to tackle it.
Read More

Links redirecting out of this site are provided as a convenience but are not Gilead property nor are controlled by Gilead. Thus, Gilead is not responsible for their content or your use of them.

Close Leave site

Q&A: How COVID-19 is impacting HIV care in Asia-Pacific

By Devex Editor

A new survey reveals the extent to which COVID-19 is wreaking havoc on HIV care and prevention in the Asia-Pacific region. Sustained Health Initiatives of the Philippines' Dr. Katerina Leyritana lays out what that looks like in the Philippines.
Read More

Links redirecting out of this site are provided as a convenience but are not Gilead property nor are controlled by Gilead. Thus, Gilead is not responsible for their content or your use of them.

Close Leave site

Q&A: Putting AIDS back on the priority list in Asia

By Devex Editor

HIV/AIDS may have fallen off the priority list for many countries and international bodies with the arrival of COVID-19, but advocacy for adequately funded responses must continue, according to Dr. Adeeba Kamarulzaman, president of the International AIDS Society.
Read More

Links redirecting out of this site are provided as a convenience but are not Gilead property nor are controlled by Gilead. Thus, Gilead is not responsible for their content or your use of them.

Close Leave site

Q&A: How to tackle HIV stigma within health care setting

By Devex Editor

Unfortunately, health facilities are far from stigma-free, according to Dr. Ishwar Gilada, founder of India’s first AIDS clinic. He talks about the discrimination HIV patients face and how he tackles it.
Read More

Links redirecting out of this site are provided as a convenience but are not Gilead property nor are controlled by Gilead. Thus, Gilead is not responsible for their content or your use of them.

Close Leave site

Q&A: Future of HIV care

COVID-19 is quickly reshaping HIV services around the world. To continue meeting the needs of people living with HIV/AIDS (PLWHA/PLHIV), the necessary growth of the healthcare sector must not come at the cost of patient-centered approaches to HIV care.
Read More

Links redirecting out of this site are provided as a convenience but are not Gilead property nor are controlled by Gilead. Thus, Gilead is not responsible for their content or your use of them.

Close Leave site

Q&A: Stepping up community leadership

When HIV first surfaced, communities were among the first responders and they remain a vital lifeline for all those at-risk or have HIV. Midnight Poonkasetwattana, APCOM’s Executive Director, opines the challenges and opportunities lying ahead in the fight against HIV/AIDS in Asia Pacific.
Read More

Links redirecting out of this site are provided as a convenience but are not Gilead property nor are controlled by Gilead. Thus, Gilead is not responsible for their content or your use of them.

Close Leave site

Q&A: The impact of Covid-19 on HIV/AIDS

By Devex Editor

How has COVID-19 impacted the fight to eliminate HIV/AIDS? Dr. Jun Yong Choi, Director of the AIDS Research Institute of Yonsei University and Chief of Division of Infectious Diseases at Severance Hospital in South Korea, explains.
Read More

Links redirecting out of this site are provided as a convenience but are not Gilead property nor are controlled by Gilead. Thus, Gilead is not responsible for their content or your use of them.

Close Leave site

Opinion: Partnering across oceans to end the HIV epidemic

By Devex Editor

The UNAIDS 2020 targets have been derailed by a public health crisis but there are opportunities to work closer together. Alex Kalomparis, Vice President, Public Affairs, International at Gilead Sciences suggests looking beyond our own backyards to share solutions, to fight the epidemic.
Read More

Links redirecting out of this site are provided as a convenience but are not Gilead property nor are controlled by Gilead. Thus, Gilead is not responsible for their content or your use of them.

Close Leave site

Opinion: Collaborating to lead the region: HIV in Southeast Asia

By Devex Editor

According to UNAIDS, in 2018, the 10 countries that make up the Association of Southeast Asian Nations had a combined population of 647 million — 1.9 million of whom were living with HIV/AIDS.
Read More

Links redirecting out of this site are provided as a convenience but are not Gilead property nor are controlled by Gilead. Thus, Gilead is not responsible for their content or your use of them.

Close Leave site

Opinion: How to achieve the ‘Fourth 90’ for HIV

By Devex Editor

When it comes to HIV/AIDS, how can the global health community accelerate progress towards the fourth 90? Gilead's Amy Flood explains in a sponsored piece with Devex.
Read More

Links redirecting out of this site are provided as a convenience but are not Gilead property nor are controlled by Gilead. Thus, Gilead is not responsible for their content or your use of them.

Close Leave site

Q&A: Why eradicating HIV by 2030 is idealistic and too optimistic

By Devex Editor

Dr. Wong Chen Seong of Singapore’s National Center for Infectious Diseases explains why the 2030 HIV elimination goal is unlikely to be achieved, how great strides can still be made, and what lessons can be learned from Singapore.
Read More

Links redirecting out of this site are provided as a convenience but are not Gilead property nor are controlled by Gilead. Thus, Gilead is not responsible for their content or your use of them.

Close Leave site

Watch Grantee Videos

Watch

Read Grantee Project Blogs

Read

© 2021 Gilead Sciences, Inc. All rights reserved.

  • Terms of Use
  • Privacy Policy

GILEAD, and the GILEAD Logo are trademarks of Gilead Sciences, Inc., or its related companies. All other marks are the property of their respective owners.

  • ZH
EN
ZH